Biotech and life sciences occupiers in Bogotá typically cluster in Salitre & Connecta Business District, plan ~320 sqft per seat at high-end fit-out ($810000–1200000/sqft), and pay around 110000 COP/sqft ($31 USD) on Class A.
Biotech and life sciences occupiers in Bogotá typically cluster in Salitre & Connecta Business District, plan ~320 sqft per seat at high-end fit-out">fit-out ($810000–1200000/sqft), and pay around 110000 COP/sqft ($31 USD) on Class A.
Biotech and life sciences occupiers in Bogotá typically anchor in Salitre & Connecta Business District. Tech, BPO, multinational HQs, telecom.
Class A rent in Bogotá runs 110000 COP/sqft ($31 USD) on a 5-year lease with 5 months free. Prime submarkets sit at or modestly above the city index.
Typical biotech and life sciences fit-out targets high-end specification at $810000–1200000/sqft. Branded reception, full client-facing programming, premium furniture, and specialist AV are standard.
Plan around 320 sqft per seat blended (workstation + circulation + amenity). A 100-headcount biotech office in Bogotá typically targets 32,000 sqft of leasable area.
Cluster effects are decisive: PhD-grade talent concentrates near academic-medical anchors and translational research institutes. Deep banking, oil services, and BPO talent. Strong English fluency in international corporate. Strong feed from Universidad de los Andes, Universidad Nacional, Pontificia Javeriana.
Headline corporate tax: 35%. Net leases. 5-year terms with renewal options. Free rent of 3-6 months and TI of COP 350,000-700,000/sqm typical.
| city | Bogotá |
|---|---|
| industry | Biotech and life sciences |
| naics | 541714, 541715, 325412 |
| preferredSubmarket | Salitre & Connecta Business District |
| preferredFitoutSpec | High-end |
| fitoutBand | $810000–1200000/sqft |
| sqftPerSeat | 320 |
| classARentLocal | 110000 COP/sqft/yr |
| classARentUsd | $31/sqft/yr |
| vacancyPct | 14.6% |
| typicalLeaseYears | 5 |
| typicalRentFreeMonths | 5 |
| talentIndex | 76 |
| corporateTaxPct | 35% |
Reviewed by Miriam Hollander — Lead market analyst. Last updated 2026-04-15. See our methodology and editorial standards.